Non Hodgkin Lymphoma Clinical Trial

A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin’s Lymphomas

Summary

This study is being done to evaluate the safety, tolerability and effectiveness of Oral CG-806 for the treatment of patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas who have failed or are intolerant to two or more lines of established therapy or for whom no other treatment options are available.

View Full Description

Full Description

This is a multicenter, open-label, Phase Ia/b dose escalation study of safety, pharmacodynamics, and pharmacokinetics of CG-806 in ascending cohorts (3+3 design) to determine the MTD or recommended dose in patients with relapsed or refractory CLL/SLL or Non-Hodgkin's Lymphoma patients. This is to be followed by a cohort expansion phase at the MTD or recommended oral dose.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Age ≥ 18 years
Life expectancy of at least 2 months
ECOG Performance Status ≤ 2
Patients must be able to swallow capsules
Adequate hematologic parameters, unless cytopenias are disease caused
Adequate renal, liver and cardiac function parameters

Exclusion Criteria:

Patients with GVHD requiring systemic immunosuppressive therapy
Uncontrolled leptomeningeal disease, auto-immune hemolytic anemia and uncontrolled and clinical significant disease related metabolic disorder
Clinically significant intravascular coagulation
Treatment with other investigational drugs within 14 days prior to first study treatment administration

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 1

Estimated Enrollment:

160

Study ID:

NCT03893682

Recruitment Status:

Recruiting

Sponsor:

Aptose Biosciences Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 31 Locations for this study

See Locations Near You

Mayo Clinic Phoenix
Phoenix Arizona, 85054, United States
University of California Los Angeles
Los Angeles California, 90095, United States
Pacific Cancer Care
Monterey California, 93940, United States More Info
Monu Sinha
Contact
831-375-4105
[email protected]
Michael Z. Koontz, MD
Principal Investigator
Torrance Memorial Physician Network
Redondo Beach California, 90277, United States More Info
Marina Marquez
Contact
310-750-3376
[email protected]
Swati Sikaria, MD
Principal Investigator
UCSD Moores Cancer Center
San Diego California, 92093, United States More Info
Colin McCarthy
Contact
858-534-8127
[email protected]
Paul Chung
Contact
858-822-5375
[email protected]
Erin Reid, MD
Principal Investigator
Sharp Clinical Oncology Research
San Diego California, 92123, United States More Info
Andrew Berrier, RN, CCRC
Contact
619-740-5810
[email protected]
Kai Zu, MD
Principal Investigator
Ridley-Tree Cancer Center
Santa Barbara California, 93105, United States
St. Joseph Heritage Heathcare
Santa Rosa California, 95403, United States
Rocky Mountain Cancer Centers
Aurora Colorado, 80012, United States More Info
Patricia Gibson, RN, BSN, CRC
Contact
303-418-7639
[email protected]
John M. Burke, MD
Principal Investigator
Mayo Clinic Jacksonville
Jacksonville Florida, 32224, United States More Info
Niti Desai
Contact
904-953-4521
[email protected]
James Foran, MD
Principal Investigator
Orlando Health
Orlando Florida, 32806, United States More Info
Karin Donaldson, RN, CCRC
Contact
321-841-9821
[email protected]
Jose Sarriera, MD
Principal Investigator
Fort Wayne Medical Oncology and Hematology
Fort Wayne Indiana, 46804, United States More Info
Shelley Seabolt, RN, MSN
Contact
260-436-0800
[email protected]
Ahad Sadiq, MD
Principal Investigator
University of Maryland, Greenebaum Comprehensive Cancer Center
Baltimore Maryland, 21201, United States
The Center for Cancer and Blood Disorders a division of American Oncology Partners of Maryland, PA
Bethesda Maryland, 20817, United States More Info
Natalie Bongiorno
Contact
301-571-2016
[email protected]
Victor Priego, MD
Principal Investigator
UMass Memorial Medical Center
Worcester Massachusetts, 01655, United States
University of Michigan
Ann Arbor Michigan, 48109, United States
Mayo Clinic Rochester
Rochester Minnesota, 55905, United States More Info
Michelle Amundson
Contact
507-293-1933
[email protected]
Jose C Villasboas Bisneto, MD
Principal Investigator
SCL Health, St. Vincent Frontier Cancer Center
Billings Montana, 59102, United States More Info
Heather Duyck
Contact
406-238-6996
[email protected]
Patrick Cobb, MD
Principal Investigator
Morristown Medical Center
Morristown New Jersey, 07960, United States More Info
Leah Zitelli, BSN, RN, OCN
Contact
973-971-6312
[email protected]
Mohamad Cherry, MD, MS
Principal Investigator
Manhattan Hematology Oncology
New York New York, 10016, United States
Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States
Prisma Health - ITOR
Greenville South Carolina, 29605, United States More Info
Jill Roemmich, RN
Contact
864-455-6962
[email protected]
Elizabeth Cull, MD
Principal Investigator
Carolina Blood and Cancer Care Associates
Rock Hill South Carolina, 29732, United States
Texas Oncology - Austin-Midtown
Austin Texas, 78705, United States More Info
Michelle Owens
Contact
512-421-4100
[email protected]
Jason Melear, MD
Principal Investigator
Texas Oncology - Baylor Charles A. Sammons Cancer Center
Dallas Texas, 75246, United States
Texas Oncology - Fort Worth Cancer Center
Fort Worth Texas, 76104, United States
University of Texas, M.D. Anderson Cancer Center
Houston Texas, 77030, United States More Info
Jennifer Ramos, BSN, RN
Contact
713-563-5426
[email protected]
Felipe Samaniego, MD
Principal Investigator
University of Texas Health Science Center at San Antonio, Mays Cancer Center
San Antonio Texas, 78229, United States More Info
Epp Goodwin
Contact
210-450-5798
[email protected]
Daruka Mahadevan, MD, PhD
Principal Investigator
Texas Oncology - Tyler
Tyler Texas, 75702, United States
Virginia Oncology Associates
Norfolk Virginia, 23502, United States More Info
Karen McClain
Contact
757-213-5658
[email protected]
Paul Conkling, MD
Principal Investigator
Northwest Cancer Specialists, P.C. - Compass Oncology
Vancouver Washington, 98684, United States More Info
Susan Papenfuse, R.N.
Contact
360-449-6521
[email protected]
David Cosgrove, M.D.
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 1

Estimated Enrollment:

160

Study ID:

NCT03893682

Recruitment Status:

Recruiting

Sponsor:


Aptose Biosciences Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.